Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in BDTX — Black Diamond Therapeutics, Inc.

CIK 861177 NEW YORK, NY
Back to BDTX Full portfolio

Position in BDTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$508
-$77 QoQ
Shares Held
275
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 96 holders
Holding Since
Dec 2020
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BDTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. BDTX ranks #200 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,086,683 $1,533,248,041
2 REGN
Regeneron Pharmaceuticals, Inc.
 716,560 $446,803,817
3 ALNY
Alnylam Pharmaceuticals, Inc.
 727,848 $219,104,078
4 INCY
Incyte Corp
 1,508,720 $171,028,494
5 RVMD
Revolution Medicines, Inc.
 912,335 $170,862,094
6 INSM
INSMED Inc
 1,335,071 $142,345,265
7 IONS
Ionis Pharmaceuticals Inc
 1,454,672 $115,340,938
8 MRNA
Moderna, Inc.
 1,521,849 $106,575,080

All Filings in BDTX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $508 275
2026-03-31 $585 275
2025-06-30 $248,000 100,000
2024-09-30 $80,910 18,600
2024-06-30 $86,676 18,600
2021-09-30 $203,886 24,100
2021-06-30 $293,779 24,100
2021-03-31 $254,730 10,500
2020-12-31 $240,375 7,500